Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Adding vancomycin to the antibiotic regimen is recommended for the treatment of pneumococcal meningitis in adults. Use of dexamethasone as adjunct therapy has proved to reduce mortality and neurologic sequelae in adult patients with pneumococcal meningitis. However, use of dexamethasone may impair penetration of vancomycin in cerebrospinal fluid. In a purely observational manner, we thought to measure blood and CSF concentrations of vancomycin in adult patients with pneumococcal meningitis, treated with vancomycin, third-generation cephalosporin and dexamethasone.
| Condition |
|---|
|
Pneumococcal Meningitis |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Prospective |
| Official Title: | Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis Treated With Dexamethasone |
| Enrollment: | 14 |
| Study Start Date: | December 2002 |
| Study Completion Date: | November 2005 |
Because of a considerable increase in streptococcus pneumoniae meningitis with penicillin nonsusceptible strains, it is now largely recommended to add vancomycin to the third-generation cephalosporin antibiotic regimen. It has also been recently shown that use of dexamethasone reduces mortality and unfavorable outcome in adults with pneumococcal meningitis. However, concern has arisen, that dexamethasone may impair penetration of vancomycin in cerebrospinal fluid.
We therefore thought to measure in a purely observational study, blood and CSF vancomycin concentrations in adult patients with pneumococcal meningitis hospitalized in medical intensive care unit that received third-generation cephalosporin, vancomycin and dexamethasone. The aim of the study was to observe whether or not sufficient concentrations of vancomycin could be measured in the CSF despite the concomitant use of dexamethasone. Patients were cared for in a perfectly routine manner. There was no randomization. All patients received routine, recommended care (IDSA guidelines). There was no invasive procedure. Dexamethasone was administered according to the de Gans study (NEJM 2002). In these patients with severe meningitis, a second lumbar puncture was performed as recommended(IDSA Guidelines, CID 2004). At the same time, peripheral blood was taken. In both samples, vancomycin concentration was determined.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adults (> 18 yr) with suspicion of pneumococcal meningitis requiring intensive care unit
Exclusion Criteria:
- Allergy to one of the antibiotics used in the study
Contacts and Locations| France | |
| Service de Réanimation Médicale, CHU Louis Mourier | |
| Colombes, France, 92700 | |
| Service de Réanimation Médicale, CHU Bichat | |
| Paris, France, 75018 | |
| Service de Réanimation Médicale, CHI Poissy-St-Germain | |
| Poissy, France, 78300 | |
| Principal Investigator: | Jean-Damien Ricard, MD, PhD | Assistance Publique - Hôpitaux de Paris |
| Study Chair: | Didier DREYFUSS, MD | Assistance Publique - Hôpitaux de Paris |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00162578 History of Changes |
| Other Study ID Numbers: | LMR4 |
| Study First Received: | September 9, 2005 |
| Last Updated: | July 20, 2007 |
| Health Authority: | France: Ministry of Health |
Keywords provided by Assistance Publique - Hôpitaux de Paris:
|
pneumococcal meningitis intensive care unit vancomycin dexamethasone drug diffusion in cerebrospinal fluid |
Additional relevant MeSH terms:
|
Meningitis Meningitis, Pneumococcal Meningitis, Bacterial Central Nervous System Infections Central Nervous System Diseases Nervous System Diseases Central Nervous System Bacterial Infections Bacterial Infections Pneumococcal Infections Streptococcal Infections Gram-Positive Bacterial Infections Dexamethasone acetate Dexamethasone Dexamethasone 21-phosphate BB 1101 |
Vancomycin Anti-Inflammatory Agents Therapeutic Uses Pharmacologic Actions Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Central Nervous System Agents Gastrointestinal Agents Glucocorticoids Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Antineoplastic Agents, Hormonal Antineoplastic Agents |
ClinicalTrials.gov processed this record on June 18, 2013